Related Experiment Videos
Diethyl pyrocarbonate inactivates CD39/ecto-ATPDase by modifying His-59
K N Dzhandzhugazyan1, L Plesner
1Institute of Cancer Biology, Danish Cancer Society, Copenhagen.
Biochimica Et Biophysica Acta
|May 29, 2000
Summary
Diethyl pyrocarbonate (DEPC) inactivates E-type ATPase by modifying a key histidine residue. This inactivation is reversible and prevented by UTP, suggesting a role for histidine in enzyme activity.
Area of Science:
- Biochemistry
- Enzymology
Background:
- E-type ATPase and ecto-ATPases are crucial enzymes involved in cellular energy metabolism and signaling.
- Histidyl residues are known to play important roles in enzyme active sites.
- Diethyl pyrocarbonate (DEPC) is a chemical reagent used to modify histidine residues.
Purpose of the Study:
- To investigate the role of histidyl residues in the activity of E-type ATPase and related ecto-ATPases.
- To identify specific histidyl residues critical for enzyme function using DEPC as a chemical probe.
Main Methods:
- Enzyme activity assays using rat lung membrane preparations, rat vessels, and human lymphocytes.
- Chemical modification of enzymes with DEPC under varying conditions.
- Reversal of inactivation using hydroxylamine.
- Protection studies using UTP.
- Sequence analysis of CD39-like ecto-ATPases and potato apyrase.
Main Results:
- DEPC strongly inactivated E-type ATPase and ecto-ATPase activities.
- Inactivation was reversible with hydroxylamine, confirming histidine modification.
- UTP protected enzyme activity, indicating substrate-induced conformational changes.
- Sequence analysis pointed to His-59 and His-251 in CD39 as potential targets.
- Potato apyrase, lacking His-59, was insensitive to DEPC, implicating His-59 in CD39 inactivation.
Conclusions:
- Histidine modification by DEPC is responsible for the inactivation of E-type ATPase and CD39 ecto-ATPases.
- His-59 in CD39 is an essential residue for enzyme activity, and its modification by DEPC leads to inactivation.
- Substrate binding alters enzyme conformation, preventing DEPC modification of the critical histidine residue.